AlRazan Pharma Group

What AlRazan Pharma Group does

AlRazan Pharma Group, legally Al-Razan Scientific Bureau, is a privately held Iraqi pharmaceutical services company founded in 2011 and headquartered in Baghdad. The company operates as a sole agent and exclusive channel partner for six or more international pharmaceutical manufacturers, providing an integrated three-pillar service offering: pharmaceutical import and registration with Iraqi regulatory authorities, nationwide distribution through its own warehouses and drugstores, and field-based marketing and promotion of products from represented principals.

The company's core technology and operations are anchored in physical infrastructure rather than software. It operates 4,700+ square meters of storage capacity across five Ministry of Health-registered facilities in Baghdad, including two refrigerated warehouses (600 sqm in Btaween and 2,000 sqm in Park AlSadoon) for temperature-sensitive products, plus drugstores and an office/warehouse. A field team of 86 medical sales and promotion professionals provides coverage across all Iraqi governorates, alongside a 32-person internal sales and marketing team. The company holds ISO 9001:2015 certification managed by a dedicated quality team and operates a pharmacovigilance department to meet international principal compliance requirements.

Al-Razan's revenue model combines three streams: transaction-based product distribution (notably parenteral fluids, antibiotic infusion vials, water for injection, and generic pharmaceuticals supplied to government and private buyers), professional-services fees for regulatory registration support, and professional-services fees for marketing and promotion campaigns. Its customer base is split between the Iraqi Ministry of Health / Kimadia for government supply and the private healthcare sector (pharmacies, drug stores, hospitals, healthcare institutions). Pricing is not publicly disclosed but is contract-based for B2B pharmaceutical distribution. The company operates in partnership with sister company Al Raad Group as part of an integrated distribution chain, and is privately held with no disclosed external investors.

Name

AlRazan Pharma Group

Legal name

Al-Razan Scientific Bureau

Website

https://alrazanbureau.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

AlRazan Pharma Group is a privately held Iraqi pharmaceutical services company that acts as sole agent for international drug manufacturers, providing regulatory registration, nationwide distribution, and marketing services to government (MOH-Kimadia) and private healthcare buyers across all Iraqi governorates.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

• Pharmaceutical distribution services
• Drug registration services
• Pharmaceutical marketing
• Medical product supply
• Pharmaceutical logistics

Headquarters

HQ city

Baghdad

HQ country

Iraq

HQ region

Middle East

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure, Technology or R&D

Revenue model

1. Pharmaceutical Product Distribution: Acts as sole agent for international pharmaceutical companies, distributing their products across Iraq to government (MOH-Kimadia) and private healthcare sectors. Revenue generated through product supply and distribution fees.
2. Pharmaceutical Registration Services: Regulatory support and product registration services for international pharmaceutical companies seeking market access in Iraq
3. Pharmaceutical Marketing & Promotion: Marketing and promotional services for partner pharmaceutical companies, including organizing promotional campaigns targeting healthcare professionals, pharmacies, and distributors

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

AlRazan Pharma Group (Al-Razan Scientific Bureau) provides comprehensive pharmaceutical registration, marketing, distribution, and supply chain services across Iraq. Acting as the sole agent for several international pharmaceutical companies, the company handles regulatory registration with the Iraqi Ministry of Health, nationwide distribution through refrigerated warehouses and a 86-person field sales team, and marketing/promotional services targeting healthcare professionals, pharmacies, drug stores, hospitals, and healthcare institutions.

Product overview

AlRazan Pharma Group (Al-Razan Scientific Bureau) is a full-service pharmaceutical services company operating in Iraq since 2011. The company operates as a generics supplier offering an integrated portfolio of three core services: Pharmaceutical Import & Registration (handling regulatory compliance and market entry), Distribution & Market Access (nationwide logistics and supply chain), and Pharmaceutical Marketing & Promotion (brand building and market presence). In partnership with AlRaed Scientific Bureau, the company forms a strong distribution chain serving both the government sector (MOH-Kimadia) and private healthcare market. The product portfolio includes parenteral fluids, antibiotic infusion vials, water for injection, and a broad range of generic pharmaceutical products from international manufacturers they represent.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Import & Registration Services

Quantifiable outcome

• Successfully registered numerous pharmaceutical companies and products in Iraq
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• International Pharmaceutical Companies (unspecified)coreChannel Partner/ Reseller/ DistributorAl-Razan represents several major international pharmaceutical companies in the Iraqi market, acting as their sole agent for product registration, marketing, and distribution. The company facilitates market entry for these partners by managing regulatory compliance, promotional activities, and nationwide distribution across Iraq.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Al-Hikma Pharmaceuticals: Jordan-headquartered branded and specialty generics manufacturer with manufacturing and distribution across MENA, including an established presence in Iraq. Comparable as a MENA-region pharma player with both manufacturing and market access capabilities, though Al-Hikma is a vertically integrated manufacturer versus AlRazan's agent/distributor model.
• Tabuk Pharmaceuticals: Saudi-headquartered pharma manufacturer with marketing and distribution in MENA. Comparable as a regional pharma platform operating across similar end markets, though Tabuk is larger and own-manufactures rather than acting as agent/distributor.
• SPIMACO: Saudi pharmaceutical manufacturer and distributor with regional presence across the GCC and wider MENA. Comparable as a MENA pharma company with overlapping distribution and channel customer bases (hospitals, pharmacies, government).
• Cipla: Indian global pharmaceutical company with extensive MENA distribution and partnerships. Comparable as a multinational generics player that relies on regional partners for registration and distribution in markets like Iraq, similar to how AlRazan acts as the local agent for international companies.
• EIPICO: Egyptian pharmaceutical manufacturer with exports across MENA. Comparable as a regional pharma player with similar therapeutic coverage and channel customer mix, though EIPICO primarily manufactures rather than acting as a sole agent.
• Neopharma: UAE-based pharmaceutical manufacturer with MENA distribution. Comparable as a regional pharma company operating across similar markets and targeting similar channel partners (pharmacies, hospitals, government health systems).
• Eva Pharma: Egyptian pharmaceutical manufacturer with broad MENA and Africa distribution footprint. Comparable as a regional pharma platform with similar go-to-market across private and government channels in emerging markets.
• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer with broad MENA distribution reach. Comparable as a regional pharma company serving similar markets and channel structures, though Julphar is much larger and manufactures rather than purely distributes.
• Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO Addimaa): Saudi pharmaceutical manufacturer with MENA distribution and government supply relationships. Comparable as a regional pharma player with similar essential-medicines and large-volume product overlap serving public-sector health systems.

Regional players

• PHARMALINE: Lebanese pharmaceutical manufacturer with MENA distribution. Comparable as a regional pharma company serving similar therapeutic categories and channel mixes, though primarily focused on the Levant rather than Iraq.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/alrazan-pharma-group

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AlRazan Pharma Group